Posts

Showing posts with the label Myopia market outlook

Myopia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2025 To 2035

Myopia Market Outlook Thelansis’s “Myopia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Myopia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? What insights do interviewed experts p...

Myopia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Myopia occurs when the focused image is too close to the eye's retinal photoreceptor layer. Myopia is classified into two types. The simple, less severe conditions are also known as physiological or school myopia, and they occur as a result of the correlative failure of the normal eye's refractive components. It can also be caused by an increase in the curvature of the surface of the cornea or lens and an increase in the axial diameter of the eye. Myopia of up to – 6.0 D is involved. Pathological, degenerative, malignant, or high myopia is a rare form that causes progressive elongation of the globe and accompanying stretching of the scleral wall, resulting in a high refractive error of – 6 D or higher. High myopia frequently causes choroid atrophy and subsequent retinal macular degeneration, resulting in loss of central visual acuity and an increased risk of retinal detachment, glaucoma, and strabismus. High myopia is a significant cause of legal blindness in many developed co...

Myopia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Myopia occurs when the focused image is too close to the eye's retinal photoreceptor layer. Myopia is classified into two types. The simple, less severe conditions are also known as physiological or school myopia, and they occur as a result of the correlative failure of the normal eye's refractive components. It can also be caused by an increase in the curvature of the surface of the cornea or lens and an increase in the axial diameter of the eye. Myopia of up to – 6.0 D is involved. Pathological, degenerative, malignant, or high myopia is a rare form that causes progressive elongation of the globe and accompanying stretching of the scleral wall, resulting in a high refractive error of – 6 D or higher. High myopia frequently causes choroid atrophy and subsequent retinal macular degeneration, resulting in loss of central visual acuity and an increased risk of retinal detachment, glaucoma, and strabismus. High myopia is a significant cause of legal blindness in many developed c...